# Cryocompression Therapy for Peripheral Neuropathy in Patients With Multiple Myeloma

> **NCT03870451** · NA · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 18 (actual)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy
- Plasma Cell Myeloma

## Interventions

- **DEVICE:** VascuTherm5 vascular compression device

## Key facts

- **NCT ID:** NCT03870451
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-01
- **Primary completion:** 2023-02-10
- **Final completion:** 2023-02-10
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Low accruals
- **Last updated:** 2024-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03870451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03870451, "Cryocompression Therapy for Peripheral Neuropathy in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03870451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
